ALArash Letafati

Arash Letafati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arash Letafati has a total of 208 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Low Prevalence of Human T‐Cell Lymphotropic Virus Type 1 (HTLV‐1) in a Hospital Triage Population in Tehran During 2024–2025

    by Arash Letafati, Shima Sadeghipour Marvi, Negar Asghari Hosori, Ghazale Molaverdi, Alireza Esfandiari, Nima Afshar Moghadam, Shabnam Siavoshi, Mehdi Norouzi, Sayed‐Hamidreza Mozhgani

    Background and Aims: Human T‐cell lymphotropic virus type 1 (HTLV‐1) is a retrovirus that is associated to adult T‐cell leukemia/lymphoma (ATLL) and HTLV‐1–associated myelopathy/tropical spastic paraparesis (HAM/TSP) as two major diseases of the virus. Due to limited data on its prevalence in general populations in Tehran and as this virus is endemic in Iran, this study aimed to assess HTLV‐1 prevalence among patients attending the triage unit of Imam Khomeini Hospital during 2024–2025. Methods: In this cross‐sectional study conducted between 2024 and 2025, patients presenting to the triage unit were randomly selected. Exclusion criteria included active infection with HBV, HCV, or HIV, and receiving antiretroviral therapy (ART). After obtaining informed consent, 5 mL of whole blood was collected from each participant. The DNJIA kit (ROJE Technologies, Iran) was used to extract DNA. We used primers that targeted the HBZ and Tax regions of the viral genome to do PCR amplification to find HTLV‐1. Results: Out of 197 individuals enrolled in this cross‐sectional study, 1 participant (0.51%) was positive for HTLV‐1. The HTLV‐1‐positive case was a 40‐year‐old single male with a history of both blood transfusion and prior surgery, but no history of organ transplantation, substance addiction, or travel. Most of the people who took part were men (54.3%) and married (58.9%), and their average age was 39.7 ± 12.1 years. Fisher's exact test showed a statistically significant association between HTLV‐1 positivity and a history of blood transfusion ( p = 0.015) and a significant link with a history of surgery ( p = 0.020). History of blood transfusion, organ transplantation, surgery, and addiction were reported by 3 (1.5%), 1 (0.5%), 4 (2.0%), and 1 (0.5%) participants, respectively. Foreign travel was reported by 77 (39.1%) participants, whereas 100 (50.8%) had a history of domestic travel. The most frequently visited foreign destinations were Turkey ( n = 25) and the United Arab Emirates ( n = 20). Among domestic destinations, the most commonly visited cities were Isfahan ( n = 22) and Mazandaran ( n = 19). Conclusion: The only positive case (0.51%) had known risk factors associated to HTLV‐1 infection including prior surgery and blood transfusion. Given the higher reported prevalence of HTLV‐1 in endemic regions including Iran, and the increased risk among certain populations—such as individuals with a history of intravenous drug use, multiple sexual partners, or co‐infection with other viruses—future studies should focus on these high‐risk groups and the virus prevalence over time. Targeted screening in such populations may provide a more accurate picture of the virus's distribution during different time frames for more effective control and prevention measures.

  • Open Access

    Targeted Interventions in HAM/TSP: Emerging Therapies and Future Directions – A Narrative Review

    by Meygol Mirzaei Rezaei, Mahdi Khosravi Nia, Kasra Allaei Rouzbahani, Maryam Kazemi, Negar Asghari Hosori, Mehdi Norouzi, Farzaneh Sotoudegan, Narges Eslami, Negar Ariamand, Vahid Shahnavaz, et al.

    Background and Aim: Human T‐Lymphotropic virus type 1 (HTLV‐1) infection can lead to HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), a debilitating chronic neurological disease characterized by progressive lower limb spasticity and autonomic dysfunction. Because the exact disease pathogenesis remains unclear and current management options have limited efficacy, there is a critical need for more effective therapies to reduce morbidity and mortality. This narrative review aims to review the available and diverse range of emerging treatment approaches for HAM/TSP. Methods: A comprehensive narrative review of the existing literature was conducted to assess current treatment methods, historical treatment efforts, and modern therapeutic interventions. The scope includes pharmacological, immunological, targeted, and non‐pharmacological strategies aimed at disease management. Results: Current disease‐modifying therapies primarily rely on immunomodulatory agents, such as corticosteroids and interferon‐alpha, to mitigate neuroinflammation and preserve motor function, whereas traditional antiretroviral therapies demonstrate limited clinical efficacy. Emerging targeted therapies, notably the monoclonal antibody mogamulizumab, show significant promise in reducing HTLV‐1‐infected cells and sustaining a decrease in spinal cord inflammation. Furthermore, comprehensive care must integrate treatments targeting specific cellular signaling pathways alongside vital non‐pharmacological interventions, such as physical rehabilitation and psychological support. Conclusion: The effective management of HAM/TSP necessitates a holistic, multidisciplinary approach encompassing targeted pharmacotherapy, symptomatic management, and psychosocial support. While novel interventions and disease‐modifying therapies offer promising new directions, further high‐quality, randomized clinical trials are essential to establish standard regimens, optimize dosages, and ensure long‐term efficacy and safety.

  • Open Access

    Molecular epidemiology and genotype distribution of human papillomavirus in Iran: A nationwide retrospective study of over 100,000 referred individuals

    by Amir Aboofazeli, Zahra Sadeghi, Sheida Sarrafzadeh, Narges Eslami, Parsa Ghafari, Erfan Kordi, Ali Ahangar Kani, Arash Letafati, Fariba Yarandi, Vahdat Poortahmasebi, et al.

    Background and aim: Human papillomavirus (HPV) infection is a major public health challenge worldwide, especially in developing countries. This study assessed the nationwide molecular epidemiology and HPV genotype distribution in Iran to optimize public screening and Further strategies for vaccination in the country. Materials and methods: We conducted a nationwide multicenter retrospective observational study using HPV genotyping records obtained from participating laboratories across Iran between 2015 and 2024. Prevalence estimates, genotype distributions, and temporal trends were evaluated. Data were assessed for age, sex, and time trends using descriptive statistics and generalized linear models and were analyzed using R software. Results: The overall HPV prevalence in this group was 34.7%, with 56.7% of positive cases having at least one high-risk (HR) genotype. Men showed a significantly higher overall prevalence compared to women (44.4% vs. 34.1%, p < 0.001), although women had a higher proportion of HR-HPV among positive cases (59.2% vs. 35.6%). Over time, the overall HPV positivity rate increased by 7% per year from 2015 to 2024, whereas the proportion of HR-HPV among infected individuals decreased by 23% per year, reflecting an increase in low-risk strains such as HPV-6. Although HPV-16 was the predominant HR genotype (26.5% of HR cases), 77.7% of all HR-positive individuals carried non-16/18 carcinogenic strains of HPV. Conclusion: The epidemiological profile of HPV in Iran is evolving, characterized by an increase in overall prevalence and a predominant presence of non-16/18 HR genotypes. The significant burden of diverse carcinogenic strains highlights the limitations of exclusive bivalent or quadrivalent vaccination and standard 16/18-axis screening. The implementation of gender-neutral 9-valent vaccination programs with an emphasis on men and the expansion of routine diagnostic coverage to multiple molecular platforms are recommended as critical requirements for effective cancer prevention in Iran.

  • Open Access

    Dynamic Changes in ACSL4 Following Influenza A/H1N1, A/H3N2, and Influenza B Infection

    by Arash Letafati, Simin Abbasi, Talat Mokhtari Azad, Fatemeh Saadatmand, Jila Yavarian

    Context: Ferroptosis is an understudied iron-dependent cell death pathway characterized by lipid peroxidation and has emerged as a critical mediator of virus-induced cytotoxicity and inflammation, particularly in respiratory viral infections. Objectives: This study examined the temporal regulation of ACSL4, a key pro-ferroptotic enzyme. Evidence Acquisition: A549 cells were infected with influenza A/H1N1, influenza A/H3N2, and influenza B viruses and assessed at 24 and 48 hours post-infection (hpi). ACSL4 expression was evaluated using quantitative reverse transcription-polymerase chain reaction, followed by post hoc analysis. Results: ACSL4 expression showed modest changes at 48 hpi in the A/H1N1 and A/H3N2 groups. However, a pronounced upregulation was observed at 24 hpi, particularly in the A/H1N1 group, with a log fold change increase of 1.52 (P = 0.005). The greatest downregulation was observed at 48 hpi in the influenza B group, with a significant log fold change of -4.11. Conclusions: These findings indicate the time-dependent activation of pro-ferroptotic mRNA associated with ferroptosis during influenza virus infection and suggest that ACSL4 may be a mediator of virus-induced cell death and a target for antiviral interventions.

  • Open Access

    Strain-Dependent Apoptotic Gene Expression in Influenza-Infected Lung Epithelial Cells

    by Arash Letafati, Simin Abbasi, Talat Mokhtari Azad, Sevrin Zadheidar, Jila Yavarian

    Background: Influenza viruses induce multiple programmed cell death pathways in respiratory epithelial cells. These pathways are associated with host antiviral defense but may also contribute to tissue damage through inflammation and increased disease severity, thereby functioning as a double-edged sword. Apoptosis is a major cell death pathway that regulates the fate of infected cells following viral infection. Objectives: This study evaluated the mRNA expression of BAX, BAK1, and Bcl-2, three key apoptosis-regulating genes, in A549 lung epithelial cells infected with influenza A/H1N1, A/H3N2, and influenza B viruses. Methods: A549 cells were cultured and inoculated with 100 TCID50 of influenza A/H1N1, A/H3N2, and influenza B viruses for 48 hours. Results were compared with those for uninfected control cells. At 48 hours post-infection, RNA extraction (RNJIA, ROJE) and cDNA synthesis were performed, and the mRNA expression levels of BAX, BAK1, and Bcl-2 were assessed using SYBR Green reverse transcription quantitative PCR. All analyses were based on log fold change (logFC). Differential gene expression versus control was evaluated using the Wilcoxon signed-rank test and a one-sample t test, whereas time-dependent changes within each virus group were assessed using the Kruskal-Wallis test and one-way analysis of variance, followed by pairwise post-hoc tests with Benjamini-Hochberg correction. Results: At 48 hours post-infection, BAX expression was significantly upregulated in A/H1N1-infected cells (log fold change = 2.85, P = 0.031). Although A/H3N2 also upregulated BAX expression (log fold change = 2.35, P = 0.061), this change was not significant. Minor downregulation of BAX was observed in influenza B-infected cells (log fold change = -0.26, P = 0.463). BAK1 expression was significantly upregulated in A/H3N2-infected cells (log fold change = 6.20, P = 0.019). A/H1N1-infected cells also showed BAK1 upregulation (log fold change = 2.10, P = 0.431), although this change was not significant, whereas influenza B-infected cells showed significant BAK1 upregulation (log fold change = 6.21, P = 0.025). Bcl-2 was significantly downregulated in all three infected groups (A/H1N1: log fold change = -6.05, P = 0.040; A/H3N2: log fold change = -4.02, P = 0.002; influenza B: log fold change = -0.70, P = 0.032). Conclusions: This experiment demonstrated strain-dependent regulation of apoptosis-related genes in A549 cells following infection with different influenza viruses. Significant upregulation of BAX and BAK1 after A/H1N1 infection, upregulation of BAK1 after A/H3N2 and influenza B infection, and downregulation of Bcl-2 in all infected groups suggest activation of pro-apoptotic signaling. These findings are preliminary transcriptional observations from an in vitro system and may provide insight into mechanisms involved in the regulation of pro-apoptotic genes in the apoptosis pathway.

  • Open Access

    Assessment of Awareness and Knowledge Regarding Human T‐Lymphotropic Virus Type 1 (HTLV‐1) Among Healthcare Workers at Imam Khomeini Hospital Complex, Tehran, in 2023–2024, A Cross‐Sectional Descriptive‐Analytical Study

    by Arash Letafati, Yasaman Goudarzi, Mohsen Sheikhi, Mahsa Afzali, Mehdi Norouzi, Kasra Allaei Rouzbahani, Marjan Ghasemi, Ahmadreza Sadeghi, Sayed‐Hamidreza Mozhgani

    Background and Aim: Human T‐Lymphotropic Virus Type 1 (HTLV‐1), is responsible for serious diseases such as Adult T‐cell leukemia/lymphoma (ATLL) and HTLV‐1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). This research aimed to explore the level of awareness and knowledge of HTLV‐1 among healthcare professionals working at Imam Khomeini hospital complex in Tehran to compare their knowledge in different aspects of this virus including basic knowledge, transmission, pathogenesis, prevention and treatment. Methods: This cross‐sectional, descriptive‐analytical study was conducted among healthcare personnel at Imam Khomeini Hospital Complex, Tehran, during 2023–2024. Data were collected using a validated questionnaire designed to assess knowledge and attitudes about HTLV‐1. The questionnaire underwent expert review for validity and reliability testing, including a 2‐week test‐retest process with Cohen's kappa coefficient calculation. It included demographic data, binary knowledge questions about HTLV‐1 transmission, symptoms, complications, prevention, and treatment. Results: A total of 220 healthcare workers and students (63.6% female, 36.4% male) from medical, paramedical, and service fields participated in the study. Participants' attitude and knowledge levels were assessed using correct response rates, revealing significantly higher attitude scores (64.81%) compared to knowledge scores (42.61%) based on the Wilcoxon test ( p < 0.05). Gender‐based comparisons showed no statistically significant differences in attitudes ( p = 0.30) or knowledge ( p = 0.95). Age‐group analyses using Kruskal–Wallis tests identified significant differences in knowledge performance ( p = 0.00015), with the 26–35 age group outperforming others. Job position comparisons showed no significant differences in attitude or knowledge scores ( p > 0.05). Conclusion: The study highlights a notable gap in knowledge about HTLV‐1 among healthcare professionals at Imam Khomeini Hospital Complex, despite relatively positive attitudes. Significant differences in knowledge were observed across age groups, with the 26–35 age group demonstrating better awareness. These findings underscore the need for targeted educational programs to improve HTLV‐1 knowledge, particularly among younger and less experienced staff, to enhance preventive and diagnostic capabilities.


  • Open Access

    Correction: Assessing HPV Awareness and Knowledge in Future Health Professionals: A Survey of Health Science Students in Iran

    by Arash Letafati, Shima Sadeghipour Marvi, Abuzar Nikzad, Mahdiyeh Soltani, Negar Zafarian, Zeynab Baghaei, Tahmine Mohammad Hosseini, Sheida Sarrafzadeh, Angila Ataei Pirkooh, Seyed Mohammad Jazayeri

  • Open Access

    Quantitative PCR Analysis of TSC2, ACTN4, CXCR4, and ATF1 Expression in HTLV-1-Associated Adult T-cell Leukemia/Lymphoma Compared to Healthy Controls

    by Ramin Shahbahrami, Atefeh Bahavar, Arash Letafati, Yousef Douzandegan, Vahid Shahnavaz, Zahra Navi, Sayed-Hamidreza Mozhgani, Mohammadreza Shafiei, Mehdi Norouzi

    Background: Adult T-cell leukemia/lymphoma (ATLL) is a hematologic malignancy associated with human T-cell lymphotropic virus type 1 (HTLV-1) infection. Gene expression changes play a role in its pathogenesis. Objectives: In this study, we examined the gene expression profiles of alpha-actinin-4 (ACTN4), Tuberous Sclerosis Complex 2 (TSC2), C-X-C chemokine receptor type 4 (CXCR4), and Activating Transcription Factor 1 (ATF1) in Iranian ATLL patients for the first time, contrasting the findings with those from healthy controls. Methods: This case-control study (2023 - 2024) included 20 male Iranian participants (10 ATLL patients and 10 healthy controls). From each participant, 6 ml of whole blood was collected. Samples from eligible participants were screened for HTLV-1 infection using enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). RNA was extracted and complementary DNA (cDNA) synthesis was performed. The expression of ACTN4, TSC2, CXCR4, ATF1, and viral HBZ genes was measured by Real-time PCR, using RPLP0 as the reference gene. Results: Expression of TSC2 and ACTN4 genes was significantly decreased in ATLL patients compared to healthy controls (TSC2: mean Âą SD: 0.00003 Âą 0.00004 vs. 0.00006 Âą 0.00004, P < 0.05; ACTN4: 0.0129 Âą 0.024 vs. 0.0207 Âą 0.009, P < 0.05); CXCR4 and ATF1 expression levels were slightly increased but not significantly different between groups (CXCR4: 0.147 Âą 0.154 vs. 0.139 Âą 0.09, P > 0.05; ATF1: 0.0028 Âą 0.0029 vs. 0.0015 Âą 0.0009, P > 0.05). Conclusions: Dysregulation of target genes in ATLL patients suggests HTLV-1 involvement in disease progression by modulating host cellular pathways. Although CXCR4 and ATF1 showed non-significant upward trends, the observed downregulation of TSC2 and ACTN4 warrants further investigation in a larger sample size to clarify their potential roles in ATLL pathogenesis.

  • Assessing HPV awareness and Knowledge in Future Health Professionals: A Survey of Health Science Students in Iran

    by Arash Letafati, Shima Sadeghipoor Marvi, Abuzar Nikzad, Mahdiyeh Soltani, Negar Zafarian, Zeynab Baghaei, Tahmine Mohammad Hosseini, Sheida Sarrafzadeh, Angila Ataei Pirkooh, Seyed Mohammad Jazayeri

    Human Papillomavirus (HPV) is among the most common sexually transmitted infections (STIs), with almost all sexually active individuals likely to encounter it during their lifetime. It is essential for health science students to have a comprehensive understanding of HPV, as their knowledge, attitudes, and behaviors can greatly impact patient education and decisions about vaccination or their current infection. This study aims to assess the level of awareness and knowledge about HPV among health science students and recognize the factors that influence these levels. We distributed paper questionnaires to 268 students (18–42 years) across different fields of study. Validity and reliability were assessed with 40 participants. After removing unreliable questions, a 36-item questionnaire was finalized. Awareness scores were calculated from responses, and statistical analysis was performed using IBM SPSS-27. This study examined 268 students aged 18 to 42 years, with an average age of 24.4 years (± 4.02). The median age was 24 years. Among the participants, 70.5% were female (189 subjects) and 29.5% were male (79 subjects). Students with PhD degrees in biological sciences had the highest awareness scores, averaging 16 (± 10.34). MSc students in biological sciences followed with awareness scores averaging 15.9 (± 5.83). BSc students in biological sciences had the lowest awareness scores, averaging 11.9 (± 6.43). Statistical analysis indicated that basic characteristics like sex, marital status, or having a partner did not significantly impact awareness levels among the subjects. However, the level of education was identified as a significant factor affecting awareness (p-value = 0.043). The majority of the study participants demonstrated a moderate level of knowledge about HPV. In this study awareness levels vary significantly across educational levels. However, the demographic factors such as gender, marital status, and relationship status did not notably influence the participants’ levels of awareness. These findings underscore the need for targeted educational interventions to address this knowledge gap and improve HPV awareness, especially among BSc students in biological sciences.


  • Open Access

    Prevalence of Chlamydia trachomatis in eye specimens of patients suspected of having viral keratitis: a cross-sectional study

    by Arash Letafati, Parsa Ghafari, Niloofar Mobarezpour, Mohammad Haddadi, Mersedeh Arbabinia, Zahra Rostami, Yasamin Meamarzadegan, Aniseh Dadgar, Zahra Tayebi